Published on 21 Mar 2024 on Benzinga
Shares of Lifecore Biomedical, Inc. LFCR fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes.
Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.